SynthesisDrug design, development and therapy2017

Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials.

Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.